NCODA Logo

Managing Immunotherapy Treatment Related Rash

Written by: Natasha Heimbigner, PharmD, Summit Cancer Centers Download Here Description of PQI: The use of immunotherapy in cancer treatment has expanded tremendously over the last several years. The most common adverse effects include dermatologic, gastrointestinal,...

Daratumumab (Darzalex®) for Multiple Myeloma

Written by: Lauren Trisler, PharmD, BCOP – Carle Cancer Center Download Here Description: Daratumumab injection is an anti-CD38 monoclonal antibody (mAb) FDA approved for use in a range of multiple myeloma patients including first line, transplant ineligible and...